Sign in
4

Changes in Ownership

REGENXBIO Inc. Filed Acc 0000899243-17-014577

Options or other derivatives

  • Director acquired 12,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Tasse Daniel · Director

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2017-05-24 Grant or award : show line 1 in the form Stock Option (Right to Buy) +12,500 $18.85 2027-05-24 12,500 12,500 D
Loading xslF345X03/doc4.xml…